EXHIBIT 31.2

                  CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
                       PURSUANT TO RULES 13a-14 AND 15d-14
                     OF THE SECURITIES EXCHANGE ACT OF 1934

I, Bruce Fairbairn, Chief Financial Officer of Swiss Medica, Inc. (the
"Company"), certify that:

         I have reviewed this  quarterly  report on Form 10-QSB of Swiss Medica,
Inc.

         Based on my  knowledge,  this  quarterly  report  does not  contain any
untrue  statement of a material fact or omit to state a material fact  necessary
to make the  statements  made,  in light of the  circumstances  under which such
statements  were made, not misleading with respect to the period covered by this
quarterly report.

         Based on my knowledge,  the financial  statements,  and other financial
information included in the report,  fairly present in all material respects the
financial  condition,  results of operations and cash flows of the Company as of
June 30, 2005, and for the periods, presented in the report.

         I am responsible for establishing and maintaining  disclosure  controls
and  procedures  (as  defined in Exchange  Act Rules  13a-14 and 15d-14) for the
Company and have:

            (d)   designed such disclosure controls and procedures, or caused
                  such disclosure controls and procedures to be designed under
                  my supervision, to ensure that material information relating
                  to the Company, including its consolidated subsidiaries, is
                  made known to me by others within those entities, particularly
                  during the period in which the periodic report is being
                  prepared;

            (e)   evaluated the effectiveness of the Company's disclosure
                  controls and procedures and presented in this report our
                  conclusions about the effectiveness of the disclosure controls
                  and procedures, as of the end of the period covered by this
                  quarterly report based on such evaluation; and

            (f)   disclosed in this quarterly report any change in the Company's
                  internal control over financial reporting that occurred during
                  the Company's most recent fiscal quarter that has materially
                  affected, or is reasonably likely to materially affect, the
                  Company's internal control over financial reporting; and

         I have  disclosed,  based on our most  recent  evaluation  of  internal
control over  financial  reporting,  to the Company's  auditors and to the audit
committee  of the board of  directors  (or  persons  fulfilling  the  equivalent
function):

            (j)   all significant deficiencies in the design or operation of
                  internal control over financial reporting which are reasonably
                  likely to adversely affect the Company's ability to record,
                  process, summarize and report financial information; and

            (ii)  any fraud, whether or not material, that involves management
                  or other employees who have a significant role in the
                  Company's internal control over financial reporting.

Dated:  August 13, 2005


-------------------------
Bruce Fairbairn,
Chief Financial Officer